Study suggests no increased ICU mortality risk from starch drips
There is no significant difference in critical care mortality between patients given crystalloids fluid replacement therapies and those receiving colloid solutions, according to French researchers.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
- Customised email alerts straight to your inbox (30+ alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units